Rabavert rabies vacc w-diluents
Ended Awarded
- Contract number
- SPE2DB25FX2FK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,255
Award facts
- Contract value 100% obligated
- $11,255.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,255 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Rabavert rabies vaccine with diluents. The contract, awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. The company leverages its established position as a critical supplier within the federal pharmaceutical supply chain, which has enabled it to compete effectively for DLA contracts despite the absence of specific socioeconomic set-asides.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026. This overarching IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key distributor of branded and generic prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare sites, making this rabies vaccine delivery consistent with the company's core federal contracting portfolio.
Quick answers
Who was awarded contract SPE2DB25FX2FK?
SPE2DB25FX2FK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FX2FK worth?
The government has obligated $11,255 on SPE2DB25FX2FK.
Is contract SPE2DB25FX2FK an order under another contract?
Yes. SPE2DB25FX2FK is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2FK competed?
The extent of competition for SPE2DB25FX2FK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award